Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS: Apixaban vs No Anticoagulation in Abdominal and Pelvic Surgery
NCT06523959Phase 4Recruiting
- Sponsor
- Clinical Urology and Epidemiology Working Group
- Start
- Jun 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), sponsored by Clinical Urology and Epidemiology Working Group. Started Jun 2024; status: recruiting.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT06523959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06523959.